Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 61 Records) |
| Query Trace: Lung Neoplasms and MDM2[original query] |
|---|
| Polymorphisms of p53 and MDM2 genes are associated with severe toxicities in patients with non-small cell lung cancer. Cancer biology & therapy 2014 15 (11): 1542-51. Zheng Datong, Chen Yanping, Gao Caijie, Wei Yongyue, Cao Guochun, Lu Nan, Hou Yayi, Jiang Xiuqin, Wang Jianj |
| Mouse double minute-2 homolog (MDM2)-rs2279744 polymorphism associated with lung cancer risk in a Northeastern Chinese population. Thoracic cancer 2015 Jan 6 (1): 91-6. Wang Xu, Jin Lina, Cui Jiuwei, Ma Kewei, Chen Xiao, Li W |
| MDM2 (RS769412) G>A Polymorphism in Cigarette Smokers: a Clue for the Susceptibility to Smoking and Lung Cancer Risk. Asian Pacific journal of cancer prevention : APJCP 2015 16 (9): 4057-60. Ahmad Dilshad, Bakairy Abdul Karieem, Katheri Abdull Malika, Tamimi Wale |
| Truncating mutations of PPM1D are found in blood DNA samples of lung cancer patients. British journal of cancer 2015 Mar 112 (6): 1114-20. Zajkowicz A, Butkiewicz D, Drosik A, Giglok M, Suwi?ski R, Rusin |
| Genetic Variants of the MDM2 Gene Are Predictive of Treatment-Related Toxicities and Overall Survival in Patients With Advanced NSCLC. Clinical lung cancer 2015 Sep 16 (5): e37-53. Qian Ji, Liu Hongliang, Gu Shaohua, Wu Qihan, Zhao Xueying, Wu Wenting, Wang Haijian, Wang Jiucun, Chen Hongyan, Zhang Wei, Wei Qingyi, Jin Li, Lu Da |
| Association of p53 and mdm2 in the development and progression of non-small cell lung cancer. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2015 Jul 36 (7): 5425-32. Javid Jamsheed, Mir Rashid, Julka P K, Ray P C, Saxena Alpa |
| Characterization of 298 Patients with Lung Cancer Harboring MET Exon 14 Skipping Alterations. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2016 Sep 11 (9): 1493-502. Schrock Alexa B, Frampton Garrett M, Suh James, Chalmers Zachary R, Rosenzweig Mark, Erlich Rachel L, Halmos Balazs, Goldman Jonathan, Forde Patrick, Leuenberger Kurt, Peled Nir, Kalemkerian Gregory P, Ross Jeffrey S, Stephens Philip J, Miller Vincent A, Ali Siraj M, Ou Sai-Hong Ignati |
| Prognostic potential of the MDM2 309T>G polymorphism in stage I lung adenocarcinoma. Cancer medicine 2016 May . Enokida Yasuaki, Shimizu Kimihiro, Atsumi Jun, Kakegawa Seiichi, Takase Yoshiaki, Kaira Kyoichi, Yashima Hideaki, Araki Takuya, Nakazawa Seshiru, Ohtaki Yoichi, Nagashima Toshiteru, Alexander Lezhava, Usui Kengo, Ishikawa Toshihisa, Hayashizaki Yoshihide, Takeyoshi Izu |
| The MDM2 T309G polymorphism and risk of lung cancer: an updated meta-analysis of 10,186 cases and 14,155 controls. Panminerva medica 2016 Dec 58 (4): 341-348. Tian Xiaodong, Wang Bo, Guo Juntang, Liu Xi, Zhang Tao, Liang Chaoyang, Zhou Naikang, Hou Xiaobin, Ma Yongfu, Yu Hua, Chen Lei, Ren Zhipeng, Fan Kaijie, Tian Qi |
| Oral mucosa and lung cancer: Are genetic changes in the oral epithelium associated with lung cancer? Nigerian journal of clinical practice 2017 Jan 20 (1): 12-18. Kömerik N, Yüce E, Calapo?lu N S, Ko?ar P A, Çakir M, Koparan |
| MDM2 SNP309 and SNP285 Act as Negative Prognostic Markers for Non-small Cell Lung Cancer Adenocarcinoma Patients. Journal of Cancer 2017 8 (12): 2154-2162. Deben Christophe, Op de Beeck Ken, Van den Bossche Jolien, Jacobs Julie, Lardon Filip, Wouters An, Peeters Marc, Van Camp Guy, Rolfo Christian, Deschoolmeester Vanessa, Pauwels Patri |
| Association of p73 gene G4C14-A4T14 polymorphism and MDM2 gene SNP309 with non-small cell lung cancer risk in a Chinese population. Oncology letters 2017 Aug 14 (2): 1817-1822. Li Wen, Wang Shuang Shuang, Deng Jing, Tang Jian X |
| The MDM2 rs937283 A > G variant significantly increases the risk of lung and gastric cancer in Chinese population. International journal of clinical oncology 2018 May . Chen Bifeng, Wang Jieling, Chen Yucan, Gu Xiuli, Feng Xianho |
| Individual and combined effect of TP53, MDM2, MDM4, MTHFR, CCR5, and CASP8 gene polymorphisms in lung cancer. Oncotarget 2018 Jan 9 (3): 3214-3229. Stumbryte Ausra, Gudleviciene Zivile, Kundrotas Gabrielis, Dabkeviciene Daiva, Kunickaite Agne, Cicenas Sauli |
| Association of MDM2 gene SNP 309 polymorphism and human non-small cell lung cancer susceptibility: A meta-analysis. Pathology, research and practice 2019 Jul 152538. Luan Lan, Wang Hongying, Zhao Beibei, Wang Fan, Shi Juan, Xu Xiaj |
| Interaction between common variants of MDM2 and PPP1R13L and CD3EAP and TP53 SNPs in relation to lung cancer risk among Chinese. Annals of translational medicine 2020 9 8 (15): 934. Yin Jiaoyang, Hou Wei, Vogel Ulla, Ma Yegang, Wang Chunhong, Wang Huiwen, Sun Zhenxia |
| The Genomic Characteristics of ALK Fusion Positive Tumors in Chinese NSCLC Patients. Frontiers in oncology 2020 10 726. Liu Shaokun, Huang Tanxiao, Liu Ming, He Wenlong, Zhao YingShen, Yang Lizhen, Long Yingjiao, Zong Dandan, Zeng Huihui, Liu Yuanyuan, Liao Wenting, Duan Jingxian, Gong Subo, Chen Shi |
| Association of Murine Double Minute 2 Genotypes and Lung Cancer Risk. In vivo (Athens, Greece) 0 34 (3): 1047-1052. Lin Yu-Chao, Chang Wen-Shin, Shen Te-Chun, Li Hsin-Ting, Li Chia-Hsiang, Hsiau Yu-Chen, Wang Yun-Chi, Wu Cheng-Nan, Gong Chi-Li, Wang Zhi-Hong, Tsai Chia-Wen, Hsia Te-Chun, Bau DA-Ti |
| A cohort study on the association of MDM2 SNP309 with lung cancer risk in Bangladeshi population. The Korean journal of internal medicine 2020 May 35 (3): 672-681. Reza Hasan Al, Anamika Wardatul Jannat, Chowdhury Md Miraj Kobad, Mostafa Mohammad Golam, Uddin M Aft |
| Genetic alterations in epidermal growth factor receptor-tyrosine kinase inhibitor-naïve non-small cell lung carcinoma. Oncology letters 2020 5 19 (6): 4169-4176. Yamaura Takumi, Muto Satoshi, Mine Hayato, Takagi Hironori, Watanabe Masayuki, Ozaki Yuki, Inoue Takuya, Fukuhara Mitsuro, Okabe Naoyuki, Matsumura Yuki, Hasegawa Takeo, Osugi Jun, Hoshino Mika, Higuchi Mitsunori, Shio Yutaka, Suzuki Hiroyu |
| Genetic Polymorphisms and Platinum-Based Chemotherapy-Induced Toxicities in Patients With Lung Cancer: A Systematic Review and Meta-Analysis. Frontiers in oncology 2020 4 9 1573. Liu Wenhui, Wang Ying, Luo Jianquan, Yuan Haiyan, Luo Zhiyi |
| MDM2 SNP 285 is Associated with Reduced Lung Cancer Risk in Bangladeshi Population. Mymensingh medical journal : MMJ 2020 1 29 (1): 108-114. Reza H A, Anamika W J, Mostafa M G, Chowdhury M K, Uddin M |
| Mutational characteristics of bone metastasis of lung cancer. Annals of palliative medicine 2021 9 10 (8): 8818-8826. Huang Xin, Shi Xiaoliang, Huang Donghua, Li Binghao, Lin Nong, Pan Weibo, Yan Xiaobo, Li Hengyuan, Hao Qing, Ye Zhaomi |
| The cell cycle regulatory gene polymorphisms TP53 (rs1042522) and MDM2 (rs2279744) in lung cancer: a meta-analysis. Vavilovskii zhurnal genetiki i selektsii 2021 5 24 (7): 777-784. Bulgakova O, Kussainova A, Bersimbaev |
| The genomic landscape of young and old lung cancer patients highlights age-dependent mutation frequencies and clinical actionability in young patients. International journal of cancer 2021 Apr . Cai Lei, Chen Yong, Tong Xiaoling, Wu Xue, Bao Hua, Shao Yang, Luo Zhuang, Wang Xuming, Cao Ya |
| Biomarkers of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Beyond PD-L1. Clinical lung cancer 2021 4 22 (5): 381-389. Cabezón-Gutiérrez Luis, Custodio-Cabello Sara, Palka-Kotlowska Magda, Alonso-Viteri Soledad, Khosravi-Shahi Parh |
| KRT-232 and navitoclax enhance trametinib's anti-Cancer activity in non-small cell lung cancer patient-derived xenografts with KRAS mutations. American journal of cancer research 2021 1 10 (12): 4464-4475. Zhang Xiaoshan, Zhang Ran, Chen Huiqin, Wang Li, Ren Chenghui, Pataer Apar, Wu Shuhong, Meng Qing H, Ha Min Jin, Morris Jeffrey, Xi Yuanxin, Wang Jing, Zhang Jianhua, Gibbons Don L, Heymach John V, Meric-Bernstam Funda, Minna John, Swisher Stephen G, Roth Jack A, Fang Binglia |
| Genomic and clinical characteristics of MET exon14 alterations in a large cohort of Chinese cancer patients revealed distinct features and a novel resistance mechanism for crizotinib. Journal of Cancer 2021 1 12 (3): 644-651. Cheng Tianli, Gu Zhongping, Song Danni, Liu Sisi, Tong Xiaoling, Wu Xue, Lin Zhifeng, Hong W |
| Genome-wide CRISPR/Cas9 screening for therapeutic targets in NSCLC carrying wild-type TP53 and receptor tyrosine kinase genes. Clinical and translational medicine 2022 6 12 (6): e882. Wang Qianqian, Li Jun, Zhu Jing, Mao Jiaqi, Duan Chao, Liang Xiao, Zhu Lingyun, Zhu Mengyan, Zhang Zhihong, Lin Fan, Guo Renh |
| Correlation of PD-L1 Expression with Clinicopathological and Genomic Features in Chinese Non-Small-Cell Lung Cancer. Journal of oncology 2022 4 2022 1763778. Li Yue, Li Chong, Jiang Ya, Han Xue, Liu Sisi, Xu Xiuxiu, Tang Wanxiangfu, Ou Qiuxiang, Bao Hua, Wu Xue, Shao Yang, Xing Minyan, Zhang Yixiang, Wang Yuezh |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 18, 2023
- Content source: